WASHINGTON U.S. medicine reviewers had actually mixed point of views concerning whether Johnson & Johnson blood thinner Xarelto minimized the threat of brand-new cardiovascular disease and strokes in individuals with heart problems, setting the stage for heated argument by outside experts later this week. Approximately 5 months ago my spouse was positioned on xeralto (without…